A Revolution in
Eye Disease Treatment

ABOUT THE COMPANY
We are an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives.
Using minimally invasive or non-invasive approaches to target the underlying causes of the world’s most prevalent eye diseases, we seek to create more effective treatment paradigms that enhance patient care and supplant conventional outdated approaches. Our OMNI® Surgical System is a safe, minimally invasive glaucoma surgery (MIGS) device indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma (POAG), the leading cause of irreversible blindness. Our TearCare® System is 510(k) cleared for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), enabling office-based clearance of gland obstructions by physicians to address the leading cause of dry eye disease.
  • LEADERSHIP TEAM
  • BOARD OF DIRECTORS
grafic lines 4
Paul Badawi
FOUNDER & CHIEF EXECUTIVE OFFICER
Founder and Chief Executive Officer of Sight Sciences, Inc. He is a co-inventor of the OMNI™ Surgical System, VISCO360® Viscosurgical System, TRAB®360 Trabeculotomy System, Helix™ Microstent, and TearCare®.
Prior to launching Sight Sciences, Paul led the U.S. healthcare venture capital practice for 3i Group, a global private equity firm.

At 3i, Paul managed a portfolio of 12 medical device investments and $120MM invested. He served as a lead investor and board member for Ulthera (acquired by Merz), Xthetix (acquired by J&J), NeoGuide (acquired by Intuitive Surgical), OmniGuide, and Sotera Wireless, and as an observer on the boards of Small Bone Innovations (acquired by Stryker), Zonare (acquired by Mindray), and Transmedics. Prior to entering the medical device world, Paul worked at the National Institutes of Health as a Research Fellow in the biochemical genetics laboratory of a Nobel Prize-winning scientist credited with cracking the genetic code. Paul received a BS in Biological Sciences from the University of Chicago, an MBA from UCLA, and is a graduate of the Kauffman Fellows Program.

read more read less
Dr. David Badawi, MD
FOUNDER & CHIEF TECHNOLOGY OFFICER
Founder and Chief Technology Officer of Sight Sciences, Inc. He is a co-inventor of the OMNI™ Surgical System, VISCO360® Viscosurgical System, TRAB®360 Trabeculotomy System, Helix™Microstent, and TearCare®.
David leads the company’s application and development of technology towards the treatment of the underlying causes of ophthalmic disease.

He also oversees the preclinical and clinical development of each of the company’s products. In addition to building Sight Sciences and helping to bring multiple innovative technologies to the operating room and the ophthalmology clinic, David runs a busy referral and surgical practice in the Chicago suburbs. David received a BS in Microbiology from the University of Maryland and an MD from Georgetown University. He completed his residency in ophthalmology at the Jules Stein Eye Institute at UCLA and a cornea fellowship at Emory University.

read more read less
Ali Bauerlein
CHIEF FINANCIAL OFFICER
Chief Financial Officer of Sight Sciences, Inc. She brings to Sight Sciences experience leading global finance and accounting functions, including revenue management, U.S. Securities and Exchange Commission (“SEC”) reporting, investor relations and business development.
Ali Bauerlein joined Sight Sciences from Inogen, a medical technology company offering innovative respiratory products for use in the homecare setting. Ms. Bauerlein cofounded Inogen in 2001 and served as its Chief Financial Officer from 2009 through 2021.

In this role, Ms. Bauerlein oversaw the global finance and accounting functions, including revenue management, financial planning and analysis, strategic and tactical cost analysis and forecasting, treasury, SEC reporting, investor relations, business development, risk management, tax, and treasury functions, as the Inogen scaled from start-up operations to over $350 million in annual sales. Ali has also served as a member of the board of directors of Pear Therapeutics, Inc, a software-based digital therapeutics company, since December 2021, and as a member of the board of directors of Gelesis Holdings, Inc, a biotherapeutics company since January 2022. She serves as chair of the Audit Committees of both Pear and Gelesis. Ms. Bauerlein also serves as a member of the board of directors of Koya Medical, Inc., a private company, since January 2021. Ali received a B.A. in economics/mathematics with high honors from the University of California, Santa Barbara.

read more read less
Dr. Reay H. Brown, MD
CHIEF MEDICAL OFFICER
Chief Medical Officer (CMO) of Sight Sciences, Inc. In his role as CMO, Dr. Brown works closely with the Company's research and development team on making improvements to existing products and on new product innovation, as well as with Sight Sciences' clinical and commercial teams.
Reay H. Brown, M.D. is a board certified ophthalmologist specializing in glaucoma and cataract surgery with intraocular lens implantation.

He has been in practice in Atlanta since 1988. Dr. Brown has published more than 90 peer reviewed articles on glaucoma and cataract surgery. He has served as chairman of the ASCRS Glaucoma Committee and is currently the Glaucoma Editor of EyeWorld magazine. He recently received the Senior Achievement Award from the American Academy of Ophthalmology. Dr. Brown is one of only a few ophthalmologists in Georgia to receive this prestigious award. He received the 2013 Distinguished Alumnus Award from John Hopkins University (Wilmer Eye Institute) and the 2014 Innovator Award form the American Glaucoma Society. He has given many named lectures all over the world including the Obstbaum Lecture at the 2011 ASCRS Glaucoma Day. He was selected to give the Charles D. Kelman Innovator Lecture in 2017. This international award honors Dr. Kelman, the inventor of phacoemulsification, a huge step forward in successful cataract surgery outcomes. This award has only been given to 33 innovators in eye surgery since its inception in 1985.

Dr. Brown and his wife, Dr. Mary G. Lynch, a Professor at Emory, have been awarded 25 patents for new devices and instruments to improve glaucoma and cataract surgery. Their patents on trabecular bypass are the fundamental patents for several innovative devices implanted into the outflow channel of the eye. Dr. Brown has been selected by his peers to be listed each year in Best Doctors in America and by a separate peer survey in Atlanta Magazine as one of the best ophthalmologist in Atlanta.

Dr. Brown earned his undergraduate degree from Harvard College Cum laude and completed medical school at the University of Michigan. He trained in ophthalmology at the Wilmer Eye Institute of Johns Hopkins University. He then completed a glaucoma fellowship at the Bascom Palmer Eye Institute and returned to Johns Hopkins as Chief Resident.

Dr. Brown was selected as the first Pamela Firman Professor of Ophthalmology at the Emory Eye Center. Mrs. Firman made the donation for the professorship in gratitude for Dr. Brown’s care of her eyes. He served as the Director of the Glaucoma Service at Emory for eleven years prior to entering private practice with Atlanta Ophthalmology Associates in 1999.

Drs. Brown and Lynch have two daughters, Veronica and Annie. Rounding out their household is, Lily, a loving English Mastiff. Dr. Brown is an avid runner, enjoys playing tennis and traveling with his family.

read more read less
Tim Buckley
VICE PRESIDENT OF PIPELINE STRATEGY AND SURGICAL MARKETING
Leads the Glaucoma and Corporate marketing as well as Pipeline strategy efforts for Sight Sciences. He has over 20 years experience with global market entry, sales, and marketing strategy.
Mr. Buckley's primary focus has been global product introductions in a broad range of medical markets – including devices and implants for ophthalmology, ENT, laparoscopic, and cardiovascular therapies.

Prior to joining Sight Sciences, Mr. Buckley led Medeon's commercial operations strategy. Prior to that he served as Vice President of Global Marketing and Business Development at Iridex Corporation until 2019. He held a number of key leadership positions of increasing responsibility, including executive leadership of US and global sales. Throughout his career, Mr. Buckley has focused on both early stage market development and global commercialization with expertise in launch strategy. Prior to Iridex, he was co-founder and CEO of Ocunetics, Inc. an early stage ophthalmic start-up. Mr. Buckley joined Iridex through its acquisition of Ocunetics’ technologies. He previously worked at Transcend Medical (acquired by Alcon), an ophthalmology stent start-up, and at Carl Zeiss Meditec where he led the marketing for its North American ophthalmic surgery division. Prior to 2001, Mr. Buckley gained extensive experience developing innovative devices in a product development capacity at Starion Instruments (acquired by Microline Surgical), General Surgical Innovations (acquired by Tyco Healthcare), and Lockheed Martin. Mr. Buckley holds a BS in Mechanical Engineering from the University of California, Berkeley and an MBA in Business from Santa Clara University

read more read less
Aaron Capsel
VICE PRESIDENT OF SALES AND BUSINESS OPERATIONS
Leads the business and sales operations efforts for Sight Sciences. He brings more than 20 years of experience across the technology sector enabling teams in wide variety of finance, sales, and operational roles.
Prior to joining Sight Sciences, Aaron served as Regional CFO for Zayo Group’s western region technology network infrastructure business segment, leading the team responsible for financial performance, strategic initiatives, and capital planning.

Aaron has served as senior vice president for Electric Lightwave, a private equity backed telecom infrastructure business, where he spent nearly 10 years and held numerous leadership roles, spanning from sales operations and business intelligence to corporate strategy and investor relations.

He holds a BS in Finance from University of Illinois at Urbana-Champaign and an MBA from The Keller Graduate School of Management.

read more read less
Kathy Chester
VICE PRESIDENT REGULATORY AFFAIRS
As Vice President of Regulatory Affairs, Kathy leads and directs the global regulatory affairs activities and provides guidance, strategy, and policy recommendations to the leadership team.
Prior to joining Sight Sciences, Kathy served as VP Regulatory, Quality & Compliance for Hero Health, a start-up company developing home medication dispensers. Kathy spent 6 years as the VP of Regulatory & Quality for the Hologic Diagnostics Division in San Diego and led programs such as the MDSAP single-audit certification as well as dozens of global product submissions/approvals, including the recent COVID molecular diagnostic tests.

Kathy has served as Head, Global Regulatory Affairs at Alcon in Fort Worth, Texas, for its Vision Care franchise (contact lenses, solutions, and intraocular lenses) as well as head of regulatory at one of their Surgical division’s facilities focusing on Excimer laser devices for corrective surgery (LASIK). From 2002 to 2014, she served in various leadership roles in Regulatory, Quality, and Clinical Affairs for St. Jude Medical (now Abbott) for products including: cardiac pacemakers, implantable defibrillators, and spinal cord stimulators with her last position held as Corporate Officer/Vice President, Global Regulatory. She holds a bachelor’s degree in Biomedical Engineering from Tulane University in Louisiana and the Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS).

read more read less
Jaime Dickerson, PhD
Vice President Strategic Clinical Evidence
Dr. Dickerson has worked in the pharmaceutical and medical device industry for 36 years beginning in 1984 at Alcon Laboratories where he was first employed as a biochemist, later, in Clinical Development-Glaucoma, and most recently as the Global Medical Affairs lead for surgical glaucoma.
Jaime was also with Healthpoint Biotherapeutics and Smith and Nephew where he served as Vice President of Global Clinical Operations.

Dr. Dickerson is the author of ~60 peer-reviewed publications in the fields of biochemistry, clinical ophthalmology, and chronic wounds and is a reviewer for several journals in the fields of ophthalmology and wound healing.

Dr. Dickerson received B.S. (Biology), B.A. (Chemistry), and M.S. (Biology) degrees from the University of Texas at Arlington, and his Ph.D. degree (Biomedical Sciences-Biochemistry) from the University of North Texas Health Science Center where he holds an adjunct Associate Professor appointment with the North Texas Eye Research Institute.

read more read less
Laurie Voshage Fischer
Vice President of Training and Education
Laurie joins Sight Sciences with over 25 years of experience as a medical device professional.
She has diverse experience as a global commercial education leader across various cardiovascular therapies at multiple multi-national organizations such as St. Jude Medical, Boston Scientific, Abbott, and Cardiovascular Systems Inc..

Over the course of her career Laurie has held field sales roles, served as a technical trainer in multiple geographies and ultimately took on expanded executive leadership roles in both internal sales training and external customer education.

Laurie has led training efforts in organizations ranging in yearly revenue from $240M to over $5.5B in global sales with a track record of leading functions that certify nearly 1000 cardiovascular physicians globally/year and train an average of nearly 500 field reps/year.

Laurie’s passion for bringing forward programs and educational initiatives that enable sales has led to opportunities throughout her career to build multiple training organizations that maximize individual contributions and enhance team impact. Laurie’s experience in creating customized education solutions, her dedication to cross-functional partnerships, and her passion for customer engagement and physician advocacy development will translate well to the field of ophthalmology.

read more read less
Jeff Francis
General Manager, SURGICAL GLAUCOMA
Responsible for leading the Glaucoma division for Sight Sciences surgical devices. Jeff has diverse experience in the Ophthalmic industry spanning over 20+ years in pharmaceutical, medical device and surgical.
He joined Sight Sciences in 2017 from Nestle Skin Health.

Prior to that Jeff was at Alcon Laboratories, a global leader in Ophthalmology, where he held positions of increasing responsibility in sales, sales leadership, marketing, training, and hospital/corporate account leadership. Most recently, Jeff held the position of VP of Glaucoma Sales at Sight Sciences where he built the US Surgical Sales infrastructure from the ground up. Throughout his career Jeff has demonstrated passion and excellence with a rich history of building, developing and empowering high performing cultures. He is deeply committed to advancement of eye care. Jeff holds a bachelor’s degree from the University of Kansas.

read more read less
Jeremy Hayden
Chief Legal Officer
Leads our legal and compliance functions. Jeremy has more than twenty years’ experience representing successful companies across a variety of industries.
Jeremy commenced his career as a corporate and securities attorney practicing for several international law firms where he specialized in capital markets transactions, M&A and technology transfer transactions.

Since 2012, Jeremy has worked exclusively in senior legal positions for innovative medical device companies, including serving as Assistant General Counsel for Volcano Corporation, General Counsel and Vice President of Business development for Cytori Therapeutics, Inc. and General Counsel for Endologix, Inc. Jeremy holds a J.D. from University of Michigan Law School and an A.B. in Politics from Princeton University.

read more read less
Rob Hill
VICE PRESIDENT OF INTERNATIONAL SALES
Rob has 25 years experience of successfully launching innovative and disruptive ophthalmic technology in OUS markets with a strong background in product distribution and international sales.
Prior to joining Sight, Rob has held international sales leadership, managing director and CEO roles with multiple multi-national organizations such as IntraLase, Malosa Medical, Calhoun Vision and most recently Avedro.

Rob has built a strong personal and professional network of global Key Opinion Leaders and commercial partners while building and managing commercial infrastructure that contributed to the creation of world leading markets for multiple innovation driven enterprises.

Rob brings an extensive amount of leadership and business acumen, specifically in the global markets, to the Sight Sciences leadership team. Rob holds a degree in Business Administration & Finance from Coventry University, UK.

read more read less
Todd Love
VICE PRESIDENT OF SALES, DRY EYE
Responsible for leading the sales force for Sight Sciences’ dry eye portfolio.
He has extensive experience in the optometric industry spanning nearly 20 years in a variety of sales, marketing, and professional development leadership roles in which he consistently increased company value, delivered business results and successfully launched major global brands.

Todd joined Sight Sciences from Bausch + Lomb where he was Director, Professional Strategy and led the development of key opinion leaders, optometric institutions and professional programs. Prior, Todd held positions of increasing responsibility at Alcon Laboratories in sales, sales leadership, market development, global marketing and brand management where he led the company’s global contact lens care franchise. During his tenure at Alcon, he was awarded PM360’s Trailblazer Award for Industry Wide Marketing Innovation. Todd holds a bachelor’s degree in business administration from the University of Houston.

read more read less
Dave Needleman
VP - Operations & Manufacturing Engineering
Leads the Manufacturing Engineering and Operations department responsible for sustaining commercial production and NPI activities.
Dave has nearly 25 years of experience in medical device product development and operations.

Prior to joining Sight Sciences, Dave was VP of R&D at Meditrina Medical developing and launching a 510(k)-cleared hysteroscope & tissue resection system. Other roles include Director of R&D at BAROnova producing a PMA-approved weight loss therapy, developing and manufacturing novel spinal implants (Benvenue Medical), urological access and treatment devices (Percutaneous Systems), and articulating laparoscopic surgical instruments (Pivotal Medical).

Dave holds a degree in Mechanical Engineering from Brown University.

read more read less
Daniel O'Keeffe
VICE PRESIDENT OF RESEARCH & DEVELOPMENT
Co-inventor of the OMNI®Surgical System, VISCO360® Viscosurgical System, TRAB®360 Trabeculotomy System, Helix™ Microstent, and TearCare®.
Daniel has been instrumental in the successful growth and development of Sight Sciences since the company’s earliest days.

Prior to joining Sight Sciences and entering the world of ophthalmology, Daniel amassed over ten years of successful research and development product development experience in cardiovascular catheters, vascular surgery delivery systems and surgical instruments. Daniel has designed and developed innovative products for industry leaders such as Boston Scientific and smaller start-ups such as Aptus Endosystems. Daniel received a BS in Mechanical Engineering from the California Polytechnic State University, San Luis Obispo.

read more read less
Mark Papini
VICE PRESIDENT OF GLAUCOMA SALES
Responsible for leading the Sales organization for Sight Sciences’ surgical portfolio.
Mark has diverse experience in the Ophthalmic industry spanning over 20 years.

He joined Sight Sciences in 2019 from Alcon Laboratories where he held positions of increasing responsibility in sales, sales leadership, training, marketing, and marketing leadership both domestically and internationally. During his tenure at Alcon, Mark received numerous awards for the achievement of commercial objectives. Most recently, Mark held the position of National Account Director at Sight Sciences where he built the Academic team and the Corporate Account team. He brings a passion for building high performing, empowered teams and a strong commitment to the advancement of the glaucoma space. Mark holds a bachelor’s degree from Texas Christian University.

read more read less
Sam Park
CHIEF OPERATING OFFICER
Sam has more than 25 years of medical device start-up experience in design and operations building pre-revenue companies, and leading them through to acquisition.
Prior to joining Sight Sciences Inc., Sam served as VP of R&D and Operations at SurgRx where he led the development of EnSeal Vessel Sealing System which was purchased by Ethicon-Endo Surgery of J&J.

He also led operations at Novacept from early revenue to its acquisition by Cytyc. Sam has held various other executive and technical positions at Spineview (Expending Innovation), Arthrocare (acquired by Smith and Nephew), CardioGenesis (IPO), and Origin Medsystems (acquired by Eli Lily, later Guidant).

Before entering the medical device industry, Sam worked in aerospace at Hughes Aircraft, and Xerox Designing and Manufacturing Laser Systems.
Sam hold a BS from the University of California Irvine in Mechanical Engineering.

read more read less
Chris Pike
VICE PRESIDENT OF IT
Responsible for leading the IT team for Sight Sciences’ surgical portfolio.
As Vice President, Information Technology, Chris Pike leads Sight Sciences IT.

Before joining Sight Sciences, Chris was Vice President of IT and CIO at Allstream, a North American telecommunications and connectivity provider with responsibilities for the network architecture, technology innovation and network operations teams. Chris has more than 20 years’ experience driving IT, Security, Process, and Operational improvement programs. He is a strategic innovator adept at defining, designing and commercializing leading edge technologies. He has a degree in IT and Finance from Oregon State University.

read more read less
Brian Regan
Vice President of Strategy and Professional Relations
Brian Regan is a highly experienced healthcare operating executive with senior leadership roles focused in marketing, sales and business development at a number of leading medical technology and consumer product companies.
Prior to joining Sight Sciences, Regan was Vice President of Marketing & Development at Johnson & Johnson Vision following its acquisition of TearScience, Inc.

Regan was an executive committee member and marketing organization leader during his more than 10 years with TearScience, and through this work, is considered one of the thought leaders in the development of the evaporative dry eye market. Regan will be leveraging his broad industry experience to lead strategy across both the Surgical and Dry Eye businesses, with a focus on the company’s interactions with key opinion leaders within the Ophthalmology and Optometry specialties.

read more read less
Jim Rodberg
VICE PRESIDENT OF FINANCE AND CORPORATE CONTROLLER
Jim leads the Finance and Accounting functions for Sight Sciences. He brings diverse finance and accounting experience from both public accounting and the medical device industry.
Prior to joining Sight Sciences, Jim served as a VP at nVent Electric, leading corporate finance, internal audit and financial planning and analysis functions.

Prior to that, Jim was Director of Finance at Abbott Laboratories in the $10B+ medical device division and spent 8 years in several progressive finance and accounting roles at St. Jude Medical (prior to its acquisition by Abbott). He began his career at Deloitte in the audit and assurance practice.

Jim holds a BS in Accounting from the University of Minnesota and is a Certified Public Accountant (inactive).

read more read less
Harry Pierre Simon, Jr
Vice President of Marketing - Glaucoma
Pierre is an accomplished surgical and pharmaceutical leader, bringing over 15 years of progressive and international ophthalmic experience in sales, technical & consultative training, sales leadership, strategic marketing, product lifecycle management, and new product ideation.
Pierre brings to Sight Sciences a proven track record of performance and unique ability to “Think Beyond” that will serve us well in his appointment to Vice President of Glaucoma Marketing.

Pierre started his career with Alcon in 2008, and over his tenure excelled in many core positions. These positions included increasing responsibility in people leadership, KOL development, and global marketing. Pierre earned multiple President’s/Master’s clubs, Circle of Excellence, and Leadership Awards. His most recent responsibilities at Alcon included global marketing for Alcon’s core surgical portfolio. He has a passion for mentoring, developing talent, changing market treatment paradigms, as well as creating long lasting partnerships with surgeons & KOLs.

With a highly successful track record in developing and delivering high-quality products and commercial launch readiness programs, Pierre has led cross-functional, high-performing teams to execute strategy, develop solutions, drive projects to completion, and build programs in alignment with executive objectives. Additionally, Pierre was the Chair of Alcon’s AACE (African Ancestry Cultivating Excellence) organization, an employee resource group focused on enhancing the culture of Diversity & Inclusion for all employees while ensuring equitable opportunities for advancement and development.

Pierre holds two Bachelor’s Degrees in Marketing & Finance, and an MBA with a focus in Business Portfolio Development & Sales Leadership. Additionally, Pierre holds an International Degree in Economics, from Charles University- Prague, Czech Republic. He is a two-time published author, a TEDx speaker, and sits on the board for North Dallas ISD, mentoring students on key topics such as financial literacy, transitions into university studies, working in “Corporate America”, etc.

read more read less
Jim Sluck
VICE PRESIDENT OF MARKETING, DRY EYE
Leads dry eye marketing efforts at Sight Sciences’ for TearCare , previously Jim held similar commercial leadership positions at Galderma (skincare division of Nestle) and Alcon.
Jim Sluck brings nearly 30 years of medical industry strategy development and commercial execution to Sight Sciences.

During his 23 year tenure at Alcon, he held escalating positions of leadership in sales, managed markets, domestic marketing, global marketing and finally Head of U.S. Pharmaceutical Marketing before moving to the global leader in dermatology, Galderma, as Vice President of U.S. Prescription marketing.

Jim earned his bachelor’s degree from the University of Pittsburgh.

read more read less
Steve R. Tamayo, Jr.
Vice President and Chief Ethics & Compliance Officer
Steve is responsible for the global compliance and ethics program at Sight Sciences.
Steve has extensive management experience designing, implementing and/or operating ethics and compliance programs at various pharmaceutical and device companies.

Prior to joining Sight Sciences, Inc., Steve was the Surgical Franchise Compliance Head, US & Global Surgical Integrity & Compliance at Alcon Vision, where he was responsible for the overall direction and implementation of the Company’s Integrity & Compliance program for the Surgical Franchise of Alcon Vision.

Steve earned a bachelor’s degree in Sociology from the University of California, Santa Barbara and a law degree from the University of Oregon Law School and is a member of the New Jersey Bar.

read more read less
Dr. David Badawi, MD
FOUNDER & CHIEF TECHNOLOGY OFFICER
Founder and Chief Technology Officer of Sight Sciences, Inc. He is a co-inventor of the OMNI™ Surgical System, VISCO360® Viscosurgical System, TRAB®360 Trabeculotomy System, Helix™Microstent, and TearCare®.
David leads the company’s application and development of technology towards the treatment of the underlying causes of ophthalmic disease. He also oversees the preclinical and clinical development of each of the company’s products.

In addition to building Sight Sciences and helping to bring multiple innovative technologies to the operating room and the ophthalmology clinic, David runs a busy referral and surgical practice in the Chicago suburbs.

David received a BS in Microbiology from the University of Maryland and an MD from Georgetown University. He completed his residency in ophthalmology at the Jules Stein Eye Institute at UCLA and a cornea fellowship at Emory University.

read more read less
Paul Badawi
FOUNDER & CHIEF EXECUTIVE OFFICER
Founder and Chief Executive Officer of Sight Sciences, Inc. He is a co-inventor of the OMNI™ Surgical System, VISCO360® Viscosurgical System, TRAB®360 Trabeculotomy System, Helix™ Microstent, and TearCare®.
Prior to launching Sight Sciences, Paul led the U.S. healthcare venture capital practice for 3i Group, a global private equity firm.

At 3i, Paul managed a portfolio of 12 medical device investments and $120MM invested. He served as a lead investor and board member for Ulthera (acquired by Merz), Xthetix (acquired by J&J), NeoGuide (acquired by Intuitive Surgical), OmniGuide, and Sotera Wireless, and as an observer on the boards of Small Bone Innovations (acquired by Stryker), Zonare (acquired by Mindray), and Transmedics. Prior to entering the medical device world, Paul worked at the National Institutes of Health as a Research Fellow in the biochemical genetics laboratory of a Nobel Prize-winning scientist credited with cracking the genetic code. Paul received a BS in Biological Sciences from the University of Chicago, an MBA from UCLA, and is a graduate of the Kauffman Fellows Program.

read more read less
Brenda Becker
BOSTON SCIENTIFIC
Brenda Becker has served as a member of our Board since March 2022.

Since 2007, Ms. Becker has served as the Senior Vice President, Global Government Affairs for Boston Scientific. Prior to joining Boston Scientific in 2007, Ms. Becker served in the George W. Bush administration under former Vice President Dick Cheney as Assistant to the Vice President for Legislative Affairs. In that capacity, she advised the Vice President and senior White House staff on legislative strategy from 2004 to 2007. In addition, from 2001 to 2004, Ms. Becker served as the Assistant Secretary for Legislative and Intergovernmental Affairs at the U.S. Department of Commerce where she provided counsel to the Secretary of Commerce and other senior commerce officials. Ms. Becker holds a B.A. in Political Science and Public Administration from Michigan State University and an M.B.A. from Central Michigan University.

read more read less
Staffan Encrantz
ALLEGRO INVESTMENT FUND, L.P.
Staffan Encrantz has served as Chairperson of the Board since 2017.

Mr. Encrantz is the President and Founder of Allegro Investment Inc., the investment manager of Allegro Investment Fund, L.P., and has served as such since 1997. Mr. Encrantz holds a Bachelor of Law and a Business Studies degree from Uppsala University, Sweden.

read more read less
Erica Rogers
SILK ROAD MEDICAL
Erica Rogers has served as a member of our Board since November 2019.

Since October 2012, Ms. Rogers has served as President and Chief Executive Officer and a member of the board of directors of Silk Road Medical, a
medical device company. Ms. Rogers also served as a member of the board of directors and member of the compensation and audit committee of Lucira Health, a diagnostics company, from August 2020 to September 2022, and currently serves as an advisor to Alydia Health and Venture Investors. Ms. Rogers holds a B.S. in Zoology from San Diego State University.

read more read less
Catherine Mazzacco
Catherine Mazzacco has served as a member of our Board since June 2023.

Ms. Mazzacco was Chief Executive Officer and President of LEO Pharma, a privately owned global pharmaceutical company, and a member of its board of directors, from August 2019 to November 2021. Prior to this role, Ms. Mazzacco was Senior Vice President, Global Commercial Operations, Life Sciences Division at GE HealthCare, a leading global medical technology, pharmaceutical diagnostics and life sciences company, from February 2018 to May 2019. Before joining GE HealthCare, Ms. Mazzacco spent over 25 years at Abbott Laboratories, a major multinational publicly traded healthcare company where she held several global senior operational and strategic leadership roles, including Vice President, Global Commercial Operations, Abbott Vision Division from 2011 to 2017. Ms. Mazzacco has served as a member of the board of directors of Krystal Biotech, Inc. since March 2023 and is a member of its Nominating and Corporate Governance Committee and its Commercial Advisory Committee. Ms. Mazzacco is a Member of the Supervisory Board and Remuneration & Nomination Committee of Servier, a privately owned global pharmaceutical company. Ms. Mazzacco holds a Bachelor of Science in Engineering, Option Biotechnology from the University of Compiègne in France.

read more read less
Don Zurbay
PATTERSON COMPANIES
Donald Zurbay has served as a member of our Board since July 2020.

Since October 2022, Mr. Zurbay has served as the Chief Executive Officer of Patterson Companies, a global medical device company. From June 2018 to October 2022, Mr. Zurbay served as the Chief Financial Officer of Patterson Companies. From March 2004 to February 2017, Mr. Zurbay held various leadership positions at St. Jude Medical, Inc., where he most recently served as Vice President and Chief Financial Officer from August 2012 to January 2017. Mr. Zurbay currently serves on the board of Silk Road Medical and served on the board of Avedro, Inc. from July 2017 to November 2019. Mr. Zurbay holds a B.S. in Business Accounting from the University of Minnesota.

read more read less
Dr. Tamara Fountain, MD
Tamara Fountain has served as a member of our Board since July 2022.

Dr. Fountain served as a member of the board of directors from January 2020 to January 2023 and as the 2021 President of the American Academy of Ophthalmology and was named to the board of directors of the American Board of Ophthalmology in January 2022. She has also served as a member of the board of directors of RxSight (NASDAQ: RXST) since January 2022. She has been on faculty at Rush University Medical Center in Chicago since May 1998 where she is professor of ophthalmology and section chair emeritus of ophthalmic plastic and reconstructive surgery. She has maintained a private practice, Ophthalmology Partners, Ltd., on Chicago’s North Shore since December 2000. Dr. Fountain was chair for Alumni Fund Giving at Harvard Medical School from January 2016 to June 2019 and served as President of the American Society of Ophthalmic Plastic and Reconstructive Surgery in 2018 and as a member of the board of directors from January 2016 to January 2020. She served 15 years on the board of directors of Ophthalmic Mutual Insurance Company (“OMIC”). At the end of her term, Dr. Fountain was elected OMIC’s first woman chair of its board of directors and chair of its audit committee, serving January 2014 to December 2015. Dr. Fountain was President of the Illinois Society of Eye Physicians and Surgeons from January 2002 to December 2005. Dr. Fountain received her B.A. in Human Biology from Stanford University, her M.D. from Harvard Medical School, and in 1992, completed her residency in ophthalmology at Johns Hopkins Hospital’s Wilmer Eye Institute.

read more read less
grafic lines 4

Careers at Sight Sciences

For information on current job openings, please contact us at E: jobs@sightsciences.com

At Sight Sciences you’ll have the opportunity to join a team dedicated to revolutionizing the way the ophthalmic and optometric communities think about and treat the leading causes of eye disease. We are seeking candidates with a passion for delivering novel, game-changing technologies and who are committed to improving patient outcomes.

Sight Sciences will process your personal information as described in this Privacy Statement and will be responsible for complying with applicable data protection laws.

We respect your privacy and will treat your personal information as confidential. We will use and share your personal information as described in this Privacy Statement.

Download Privacy Notice for Job Applicants PDF

We are an Equal Employment/Affirmative Action employer. We do not discriminate in hiring on the basis of sex, gender identity, sexual orientation, race, color, religious creed, national origin, physical or mental disability, protected Veteran status, or any other characteristic protected by federal, state, or local law.

If you need a reasonable accommodation for any part of the employment process, please contact us by email at jobs@sightsciences.com and let us know the nature of your request and your contact information. Requests for accommodation will be considered on a case-by-case basis. Please note that only inquiries concerning a request for reasonable accommodation will be responded to from this e-mail address.